Our Diagnostics Solutions
Menarini is committed to bringing innovative solutions in the In Vitro Diagnostics market and constantly expanding its portfolio to meet the ever-evolving clinical needs of patients and healthcare professionals.
With extensive investments in research, strategic alliances and presence in the healthcare community, Menarini's efforts are in two main areas of In Vitro Diagnostics: Professional Diagnostics, with Diabetes Care and Laboratory products; Advanced Diagnostics, with the most comprehensive solutions for cell-based liquid biopsy.
We are fully committed to the development of high-tech diagnostics systems and reagents to improve patients' quality of life, providing healthcare professionals with the best possible solutions for their diagnostics needs.
Diabetes Care Products
Menarini is actively operating in diabetes care with a comprehensive portfolio of glucose monitoring solutions, including our recently launched Glucomen® Day CGM.
Glucomen® Day CGM allows patients to monitor their glycemia in real time with needle-free insertion system, providing a new glucose value every minute for 14 days. Our unique concept enables a significant reduction in environmental impact, and provides a complete ecosystem for the diabetes patients, allowing them to live their condition with more serenity.
We provide innovative solutions to laboratories facilitating the decentralisation of samples testing with a wide and innovative range of point of care instruments, addressing laboratory needs for infectious diseases routines and meeting the needs of core and anatomo-pathology laboratories.
Menarini silicon biosystems offers the most comprehensive solution for cell-based liquid biopsy in oncology. Its Cellsearch® ctc test is the first and only actionable test for detecting and enumerating circulating tumor cells (ctcs) from blood in metastatic breast, prostate and colorectal cancer patients, which can support physicians in monitoring a patient’s status throughout therapy.
Together with the cellsearch technology, deparray digital single cell sorter, enable unparalleled resolution in the genetic analysis of circulating tumor cells thus unlocking precious information that in the future could guide better therapeutic strategy for cancer patients. in the field of molecular pathology, msb offers, with its deparray technology, a solution for the analysis of challenging ffpe tissue samples and the possibility to unlock genetic information from any patient’s specimen.